Ulotaront is a trace amine-associated receptor 1 agonist with 5-HT1A agonist activity.
Your search for major depressive disorder returned 9 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
This retrospective cohort study evaluated patient data from patients aged 50 years or older who received an acute course of ECT between 2011 and 2019 and were evaluated for cognition and depression outcomes on the basis of baseline cognitive function.
In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.
Researchers studied the mental health outcomes of patients with rheumatic disease during the COVID-19 pandemic.
Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.
Electronic health records from 77 health care organizations in the US were evaluated for a risk for endocarditis among patients with opioid use disorder or cocaine use disorder on the basis of contracting COVID-19.
Are patients with asthma and allergic rhinitis who initiate montelukast at higher risk for sleep and anxiety disorders?
Investigators assessed whether use of montelukast in adults with asthma is associated with onset of neuropsychiatric adverse events.
While neurological and psychiatric sequelae of COVID-19 have been reported, more data are needed to adequately assess the effects of COVID-19 on brain health.